Comparison |
Alternate Manufacturer Number |
3751377 | 3241239 | 3588647 | | 3783461 |
Container Type |
Bottle | Single-Use Vial | Bottle | Bottle | Blister Pack |
Country of Origin |
India | Unknown | United States | Unknown | India |
Dosage Form |
Tablet | Injection | Capsule | Tablet | Tablet |
Generic Drug Code |
34722 | 34680 | 34700 | 34741 | 34722 |
Generic Drug Name |
Acetazolamide | Acetazolamide | Acetazolamide | Methazolamide | Acetazolamide |
NDC Number |
64380083406 | 39822019001 | 29033003001 | 00574079001 | 00904666361 |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | | McKesson Acceptable Dating: we will ship >= 90 days |
Quantity |
100 Tablets | | 100 Capsules | 100 Tablets | 100 Tablets |
Strength |
250 mg | 500 mg / 10 mL | 500 mg | 25 mg | 250 mg |
Type |
| Intravenous | Extended Release | | Unit Dose |
UNSPSC Code |
51141501 | 51141501 | 51141501 | 51191560 | 51141501 |
Volume |
| 10 mL | | | |
Application |
Carbonic Anhydrase Inhibitor | Carbonic Anhydrase Inhibitor | Carbonic Anhydrase Inhibitor | Carbonic Anhydrase Inhibitor | Carbonic Anhydrase Inhibitor |
Features and Benefits |
|
- Available for intravenous use, and is supplied as a sterile powder requiring reconstitution
- Preservative free
- Barcoded for patient safety
|
|
- AB Rated Generic Equivalent to NeptazaneĀ®
|
|